Departure. Clinical Miss. Billion: Should You Bet on Pfizer?
Pfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
Yearly performance comparison of index funds helps you rank funds by year, track changes, and refine your allocation strategy today.
19,588 articlesPfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
In 2026, a wave of AI-powered tools is reshaping how agents manage leads, websites, and transactions as the market sh...
A British TikTok star is entangled in a Dubai murder case, raising questions about legal costs, travel insurance, and...
As humanoid robots scale from labs to factories, two equipment makers rise as the hidden winners in the trillion-doll...
Sotheby’s hosts its inaugural AI-generated artwork sale, featuring the Ai-Da robot painting a portrait of Alan Turing...
iQIYI’s stock trades near $1 after a disappointing Q1 report, but the company’s AI pivot and new capital moves set up...
CoreWeave stock tumbling today underscores the volatility in AI infrastructure plays. This explainer breaks down what...
Valr, Africa’s largest crypto exchange by trade volume, expands its derivatives with Hyperliquid, adding 200+ cross-a...
If you had $1,000 to put into a single stock this July, MercadoLibre could stand out for growth potential and a robus...
A rising chorus of retirees worries about minimum distributions draining IRA balances. Yet the IRS formula is designe...
An investor explains a dip‑buying method focused on Nvidia, detailing how long‑term AI demand and enterprise commitme...
Mark Zuckerberg showcased a bold use of wearable tech by taking a business call from a jet ski, underscoring Meta's p...